GNANAMBA V KONDAGUNTA MD NPI 1265403208

NPI Details

Gnanamba V Kondagunta, MD is a hematology and oncology internal medicine in Middletown, NY with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Gnanamba V Kondagunta, MD NPI is 1265403208. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Graduation Year:1998

The provider's business location address is:

155 CRYSTAL RUN RD
MIDDLETOWN, NY
ZIP 10941-028
Phone: (845) 703-6999
Fax: (845) 703-6297

The NPI 1265403208 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Unclassified drugs (HCPCS:J3490)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Ferritin (blood protein) level (HCPCS:82728)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood test, clotting time (HCPCS:85610)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Magnesium level (HCPCS:83735)
• Folic acid level, serum (HCPCS:82746)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Blood creatinine level (HCPCS:82565)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Red blood count, automated test (HCPCS:85045)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Liver enzyme (sgot), level (HCPCS:84450)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Bilirubin level, total (HCPCS:82247)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)

The enumeration date for this NPI number is 1/29/2006 and was last updated on 10/7/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.